For patients managing the complex, overlapping symptoms of Long COVID, ME/CFS, and dysautonomia, targeted L-Lysine supplementation may help alleviate several debilitating issues
TERLIVAZ is currently the only approved pharmacologic treatment within the broader Acute Kidney Injury (AKI) landscape, having received FDA approval in September 2022 for hepatorenal syndrome-associated AKI (HRS-AKI), a high-mortality yet comparatively niche segment of AKI
Anemia of renal disease: what it is, what to do and what's new
Retatrutide: This is the lyophilized (freeze-dried) powder in your vial
Low levels can leave you feeling tired and sluggish
Furthermore, coffee can contribute to stomach irritation and anxiety whilst you are hungover